Foundayo (Orforglipron) vs Injectable GLP-1s: How They Compare
Reviewed by Sydney Duong, RD, GLPeak Clinical Lead. Last updated 2026-06-17.
Quick answer: Foundayo (orforglipron) is the first FDA-approved daily oral non-peptide GLP-1 — no fasting window required, unlike Rybelsus. It leads to somewhat less weight loss on average than injectable semaglutide or tirzepatide, but the no-needle, no-fasting profile makes it an easy on-ramp for needle-averse patients. In its main trial, the highest dose (17.2 mg) led to 11.1% average weight loss at 72 weeks (FDA label), compared with about 15% for Wegovy 2.4 mg (STEP 1) and about 21% for Zepbound 15 mg (SURMOUNT-1) in their own trials.
Why Foundayo doesn't need a fasting window
Foundayo is a small molecule, not a peptide. Peptide drugs (semaglutide, tirzepatide) are broken down by stomach enzymes — they survive only with the help of an absorption-enhancer (Rybelsus) or by skipping the gut entirely (injection).
Because orforglipron is a small molecule, it survives the stomach on its own. That's why Foundayo can be taken any time of day, with or without food.
Side-by-side comparison
- Foundayo (orforglipron, oral daily): 0.8 → up to 17.2 mg, at least 30 days per step. No empty-stomach rule. 11.1% average weight loss at 72 weeks on 17.2 mg.
- Wegovy (semaglutide): weekly injection 0.25 → 2.4 mg (up to 7.2 mg for some adults), or a 25 mg daily pill. ~15% (2.4 mg) to ~19% (7.2 mg) average weight loss.
- Zepbound (tirzepatide, injection weekly): 2.5 → 15 mg. ~15–21% average weight loss, depending on dose.
- Rybelsus (oral semaglutide, daily): 3 → 14 mg. 30-min fasting window. Type-2-diabetes label only.
Who Foundayo is best for
- Patients who will not or cannot inject.
- People who found the empty-stomach routine of oral semaglutide hard to keep up.
- Patients who want a daily routine over a weekly shot.
- Patients prioritizing convenience over maximum weight loss.
Frequently asked questions
Can Foundayo replace weekly Wegovy or Zepbound?
It can replace them — but typically with somewhat less weight loss. For patients who are happy with their injection regimen and tolerating it well, switching for the sake of switching isn't recommended.
Does Foundayo have the same side effects as injectable GLP-1s?
Yes, same class — nausea, diarrhea, vomiting, constipation are the most common. The titration schedule reduces severity at each step, same principle as injectable GLP-1s.
Is Foundayo cheaper than injectable Wegovy or Zepbound?
At launch in April 2026, Lilly listed self-pay pricing through LillyDirect starting at $149 a month for the lowest dose, and as little as $25 a month for some people with commercial coverage. Prices and programs change, so check the LillyDirect Foundayo page for current pricing.
Related GLPeak pages
Educational only, not medical advice. Talk to your prescriber before changing any medication.